Faut-il traiter les dyslipidémies chez les personnes âgées et très âgées. [Should we treat dyslipidemia in the elderly and the oldest old?].

Details

Serval ID
serval:BIB_4A6B19AFD932
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Faut-il traiter les dyslipidémies chez les personnes âgées et très âgées. [Should we treat dyslipidemia in the elderly and the oldest old?].
Journal
Revue Médicale Suisse
Author(s)
Doser Joz-Roland N., Büla C., Rodondi N.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
2009
Volume
5
Number
224
Pages
2211-2218
Language
french
Notes
Publication types: English Abstract ; Journal Article ; Review
Abstract
Therapy of dyslipidemia in the elderly and the oldest old remains controversial. Several studies have shown benefits of statins on secondary prevention of cardiovascular disease in older adults up to 80 years, but data remain scarce after that age. Fewer studies have assessed the impact of statins in primary prevention in the elderly. Most studies have not included adults older than 75 years, and absolute risk reduction is far lower compared to secondary prevention. Use of statins for primary prevention in this age group should be based on individual decision, taking into account patient's functional and cognitive status, comorbidities and other therapies to avoid drugs interactions, with the help of shared-decision making.
Keywords
Age Factors, Aged, Aged, 80 and over, Dyslipidemias/drug therapy, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use
Pubmed
Create date
11/09/2011 13:14
Last modification date
20/08/2019 13:58
Usage data